BOX I-2Workshop Goals for “CNS Clinical Trials: Suicidality and Data Collection”

The overall purpose of the workshop on central nervous system (CNS) clinical trials is to examine what methods are best used to determine treatment- emergent suicidal behavior during the conduct of clinical trials. More specifically, attendees were asked to:

  • Review available data on the extent to which emergent suicidal ideation predicts the occurrence, in the short term, of actual suicidal behavior;
  • Identify promising methods of analysis to address whether suicidal ideation predicts the short-term occurrence of actual suicidal behavior; and
  • Examine potential partnerships between the Food and Drug Administration, pharmaceutical industry, academia, and the National Institutes of Health that could be used to facilitate data sharing from randomized clinical trials.

From: Introduction

Cover of CNS Clinical Trials
CNS Clinical Trials: Suicidality and Data Collection, Workshop Summary.
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.
Washington (DC): National Academies Press (US); 2010.
Copyright © 2010, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.